Skip to main content

Bilateral Nasolabial Fold Wrinkles

2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Castle Creek Biosciences
2 programs
2
Autologous Human FibroblastPhase 31 trial
Autologous Human FibroblastsPhase 31 trial
Active Trials
NCT00649428Completed203Est. May 2009
NCT00655356Completed218Est. May 2009

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Castle Creek BiosciencesAutologous Human Fibroblasts
Castle Creek BiosciencesAutologous Human Fibroblast

Clinical Trials (2)

Total enrollment: 421 patients across 2 trials

NCT00655356Castle Creek BiosciencesAutologous Human Fibroblasts

Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles

Start: Nov 2006Est. completion: May 2009218 patients
Phase 3Completed
NCT00649428Castle Creek BiosciencesAutologous Human Fibroblast

Safety and Efficacy Study of Isolagen TherapyTM in the Treatment of Nasolabial Fold Wrinkles

Start: Oct 2006Est. completion: May 2009203 patients
Phase 3Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.